DE602006020407D1 - Peptide mit neuropeptide-2 rezeptor agonist aktivität - Google Patents

Peptide mit neuropeptide-2 rezeptor agonist aktivität

Info

Publication number
DE602006020407D1
DE602006020407D1 DE602006020407T DE602006020407T DE602006020407D1 DE 602006020407 D1 DE602006020407 D1 DE 602006020407D1 DE 602006020407 T DE602006020407 T DE 602006020407T DE 602006020407 T DE602006020407 T DE 602006020407T DE 602006020407 D1 DE602006020407 D1 DE 602006020407D1
Authority
DE
Germany
Prior art keywords
neuropeptide
peptides
receptor agonist
agonist activity
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006020407T
Other languages
English (en)
Inventor
Waleed Danho
George Ehrlich
David C Fry
Wajiha Khan
Joseph Swistok
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE602006020407D1 publication Critical patent/DE602006020407D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57545Neuropeptide Y
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602006020407T 2005-01-18 2006-01-11 Peptide mit neuropeptide-2 rezeptor agonist aktivität Active DE602006020407D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64484005P 2005-01-18 2005-01-18
PCT/EP2006/000161 WO2006077035A1 (en) 2005-01-18 2006-01-11 Peptides with neuropeptide-2 receptor (y2r) agonist activity

Publications (1)

Publication Number Publication Date
DE602006020407D1 true DE602006020407D1 (de) 2011-04-14

Family

ID=36118121

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006020407T Active DE602006020407D1 (de) 2005-01-18 2006-01-11 Peptide mit neuropeptide-2 rezeptor agonist aktivität

Country Status (22)

Country Link
US (1) US7410949B2 (de)
EP (1) EP1844070B1 (de)
JP (1) JP4633804B2 (de)
KR (1) KR100905380B1 (de)
CN (1) CN101107266A (de)
AR (1) AR051904A1 (de)
AT (1) ATE500268T1 (de)
AU (1) AU2006207659B2 (de)
BR (1) BRPI0606675A2 (de)
CA (1) CA2594423A1 (de)
DE (1) DE602006020407D1 (de)
DK (1) DK1844070T3 (de)
ES (1) ES2359850T3 (de)
IL (1) IL184428A0 (de)
MX (1) MX2007008614A (de)
NO (1) NO20073664L (de)
PL (1) PL1844070T3 (de)
PT (1) PT1844070E (de)
RU (1) RU2383553C2 (de)
TW (1) TWI309653B (de)
WO (1) WO2006077035A1 (de)
ZA (1) ZA200705674B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007065808A2 (en) * 2005-12-07 2007-06-14 F. Hoffmann-La Roche Ag Neuropeptide-2 receptor-agonists
US8299023B2 (en) * 2008-09-17 2012-10-30 Hoffmann-La Roche Inc. Neuropeptide-2 receptor (Y-2R) agonists
KR20110097807A (ko) * 2008-11-05 2011-08-31 에프. 호프만-라 로슈 아게 뉴로펩티드-2-수용체(y-2r) 작용제 및 이의 용도
WO2011002066A1 (ja) * 2009-07-02 2011-01-06 武田薬品工業株式会社 ペプチド及びその用途
WO2011033068A1 (en) * 2009-09-18 2011-03-24 Novo Nordisk A/S Long-acting y2 receptor agonists
WO2011045232A2 (en) * 2009-10-13 2011-04-21 F. Hoffmann-La Roche Ag Neuropeptide-2 receptor (y-2r) agonists
JP5902194B2 (ja) 2010-12-16 2016-04-13 ノヴォ ノルディスク アー/エス Glp−1アゴニストとn−(8−(2−ヒドロキシベンゾイル)アミノ)カプリル酸の塩とを含む固形組成物
ES2952874T3 (es) 2012-03-22 2023-11-06 Novo Nordisk As Composiciones de péptidos GLP-1 y preparación de estas
JP6258928B2 (ja) 2012-06-13 2018-01-10 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 新規ジアザスピロシクロアルカンおよびアザスピロシクロアルカン
AU2013322838B2 (en) 2012-09-25 2018-02-01 F. Hoffmann-La Roche Ag New bicyclic derivatives
AR095079A1 (es) 2013-03-12 2015-09-16 Hoffmann La Roche Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
MX369818B (es) 2013-11-15 2019-11-22 Novo Nordisk As Compuestos selectivos de peptido yy (pyy) y usos de los mismos.
JP6629198B2 (ja) 2013-11-15 2020-01-15 ノヴォ ノルディスク アー/エス 35位にβ−ホモアルギニン置換を有するHPYY(1−36)
UA118201C2 (uk) 2013-11-26 2018-12-10 Ф. Хоффманн-Ля Рош Аг НОВИЙ ОКТАГІДРОЦИКЛОБУТА[1,2-c;3,4-c']ДИПІРОЛ-2-ІЛ
EA032357B1 (ru) 2014-03-26 2019-05-31 Ф. Хоффманн-Ля Рош Аг Конденсированные [1,4]диазепиновые соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa)
EA037928B1 (ru) 2014-03-26 2021-06-08 Ф. Хоффманн-Ля Рош Аг Бициклические соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa)
MA41898A (fr) * 2015-04-10 2018-02-13 Hoffmann La Roche Dérivés de quinazolinone bicyclique
AR104984A1 (es) 2015-06-12 2017-08-30 Novo Nordisk As Compuestos selectivos para pyy y sus usos
MX2020004504A (es) 2015-09-04 2021-11-10 Hoffmann La Roche Derivados de fenoximetilo.
PE20180552A1 (es) 2015-09-24 2018-04-02 Hoffmann La Roche Nuevos compuestos biciclicos como inhibidores duales de atx/ca
MA42919A (fr) 2015-09-24 2018-08-01 Hoffmann La Roche Composés bicycliques utilisés en tant qu'inhibiteurs d'atx
EP3353181B1 (de) 2015-09-24 2021-08-11 F. Hoffmann-La Roche AG Als atx-inhibitoren geeignete bicyclische verbindungen
MA42918A (fr) 2015-09-24 2018-08-01 Hoffmann La Roche Composés bicycliques utilisés en tant qu'inhibiteurs d'atx
EP3596060B1 (de) 2017-03-16 2023-09-20 F. Hoffmann-La Roche AG Neue bicyclische verbindungen als atx-inhibitoren
RU2019132254A (ru) 2017-03-16 2021-04-16 Ф. Хоффманн-Ля Рош Аг Гетероциклические соединения, пригодные в качестве дуальных ингибиторов atx/ca
WO2019106193A1 (en) 2017-12-01 2019-06-06 University Of Copenhagen Peptide hormone with one or more o-glycans
JP6898518B2 (ja) 2018-02-02 2021-07-07 ノヴォ ノルディスク アー/エス Glp−1アゴニスト、n−(8−(2−ヒドロキシベンゾイル)アミノ)カプリル酸の塩及び滑沢剤を含む固形組成物
EP3800195A1 (de) * 2019-10-03 2021-04-07 Universitat de Barcelona Peptidverbindungen zur reduzierung der nebenwirkungen von cb1-rezeptoragonisten

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5080891A (en) 1987-08-03 1992-01-14 Ddi Pharmaceuticals, Inc. Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
NZ265452A (en) 1993-03-29 1997-09-22 Univ Cincinnati Analogues of peptide yy, dimers and pharmaceutical compositions
US6017879A (en) * 1998-04-03 2000-01-25 B.M.R.A. Corporation B.V. Template associated NPY Y2-receptor agonists
US7811989B2 (en) * 2003-01-17 2010-10-12 Ipsen Pharma S.A.S. Peptide YY analogs
EP1689421A4 (de) * 2003-11-25 2009-06-24 Bayer Healthcare Ag Selektive neuropeptide-y2-rezeptoragonisten
CA2555894A1 (en) * 2004-02-11 2005-08-25 Amylin Pharmaceuticals, Inc. Pancreatic polypeptide family motifs and polypeptides comprising the same

Also Published As

Publication number Publication date
AU2006207659B2 (en) 2009-10-29
NO20073664L (no) 2007-09-28
WO2006077035A9 (en) 2006-10-26
BRPI0606675A2 (pt) 2009-07-07
MX2007008614A (es) 2007-09-11
KR20070095422A (ko) 2007-09-28
TW200637874A (en) 2006-11-01
IL184428A0 (en) 2007-10-31
US7410949B2 (en) 2008-08-12
PL1844070T3 (pl) 2011-07-29
RU2383553C2 (ru) 2010-03-10
EP1844070A1 (de) 2007-10-17
PT1844070E (pt) 2011-05-04
JP2008527017A (ja) 2008-07-24
ATE500268T1 (de) 2011-03-15
ZA200705674B (en) 2009-08-26
TWI309653B (en) 2009-05-11
CN101107266A (zh) 2008-01-16
CA2594423A1 (en) 2006-07-27
RU2007131504A (ru) 2009-02-27
EP1844070B1 (de) 2011-03-02
AU2006207659A1 (en) 2006-07-27
KR100905380B1 (ko) 2009-06-30
WO2006077035A1 (en) 2006-07-27
ES2359850T3 (es) 2011-05-27
JP4633804B2 (ja) 2011-02-16
US20060160742A1 (en) 2006-07-20
AR051904A1 (es) 2007-02-14
DK1844070T3 (da) 2011-06-14

Similar Documents

Publication Publication Date Title
ATE500268T1 (de) Peptide mit neuropeptide-2 rezeptor agonist aktivität
FR22C1054I2 (fr) Amides peptidiques synthetiques
DK1776133T3 (da) Peptid-vasopressin-receptor-agonister
ATE480555T1 (de) Antimykotische polypeptide
DE602005015131D1 (de) Interleukin-15-antagonistisches peptid
CU23872B1 (es) Anticuerpos antagonistas dirigidos contra el péptido relacionado con el gen de calcitonina
BRPI0818288A2 (pt) Proteínas conjugadas e peptídeos.
DK1973886T3 (da) Prokineticin-1-receptor-antagonister
DE602006007563D1 (de) Agonisten
DK2602263T3 (da) Polypeptider omfattende en isbindende aktivitet
DK1711465T3 (da) Hydroisoindolin-tachykinikreceptorantagonister
GB2429976B (en) Repeatable protein arrays
ATE482281T1 (de) Plastiden transit peptide
DK2035447T3 (da) Polypeptid
ATE549350T1 (de) Neuropeptid-2-rezeptor-agonisten
ATE516853T1 (de) Zyklische peptid-cxcr4-antagonisten
IS8482A (is) Kalsítóníngen-skyldir peptíðviðtaka antagónistar
IL184284A0 (en) Modified beta thymosin peptides
IL189922A0 (en) Selective vpac2 receptor peptide agonists
DE602006006428D1 (de) Material mit trennbarer struktur
DK2468292T3 (da) Nyt peptid med antisekretorisk aktivitet
ATE397618T1 (de) Peptidcyclisierung
DK1809660T3 (da) Thymus-specifikt protein
DK2207790T3 (da) Biologisk aktive C-terminalt argininholdige peptider
DK1968623T3 (da) Bacteriocin-inducer-peptider